-
公开(公告)号:US08129130B2
公开(公告)日:2012-03-06
申请号:US13051327
申请日:2011-03-18
申请人: Herren Wu , Changshou Gao , Ling-Ling An , Peter Kiener , Su-Yau Mao , Anthony Coyle , Jane Tian , Theresa O'Keefe , Shixin Qin
发明人: Herren Wu , Changshou Gao , Ling-Ling An , Peter Kiener , Su-Yau Mao , Anthony Coyle , Jane Tian , Theresa O'Keefe , Shixin Qin
IPC分类号: G01N33/53
CPC分类号: C07K16/24 , A61K38/1709 , A61K39/39 , A61K2039/505 , C07K2317/21 , C07K2317/76 , C07K2317/92 , C07K2317/94 , A61K2300/00
摘要: Compositions and methods are disclosed for inhibiting the release of a proinflammatory cytokine from a vertebrate cell, and for inhibiting an inflammatory cytokine cascade in a patient. The compositions comprise, for example, high affinity antibodies that specifically bind HMG1 and antigenic fragments thereof. The high affinity antibodies of the present invention and pharmaceutical compositions comprising the same are useful for many purposes, for example, as therapeutics against a wide range of inflammatory diseases and disorders such as sepsis, rheumatoid arthritis, peritonitis, Crohn's disease, reperfusion injury, septicemia, endotoxic shock, cystic fibrosis, endocarditis, psoriasis, psoriatic arthritis, arthritis, anaphylactic shock, organ ischemia, reperfusion injury, and allograft rejection. In addition, the high affinity antibodies of the present inventions are useful as diagnostic antibodies.
-
2.
公开(公告)号:US20110287023A1
公开(公告)日:2011-11-24
申请号:US13051327
申请日:2011-03-18
申请人: Herren Wu , Changshou Gao , Ling-Ling An , Peter Kiener , Su-Yau Mao , Anthony Coyle , Jane Tian , Theresa O'Keefe , Shixin Qin
发明人: Herren Wu , Changshou Gao , Ling-Ling An , Peter Kiener , Su-Yau Mao , Anthony Coyle , Jane Tian , Theresa O'Keefe , Shixin Qin
CPC分类号: C07K16/24 , A61K38/1709 , A61K39/39 , A61K2039/505 , C07K2317/21 , C07K2317/76 , C07K2317/92 , C07K2317/94 , A61K2300/00
摘要: Compositions and methods are disclosed for inhibiting the release of a proinflammatory cytokine from a vertebrate cell, and for inhibiting an inflammatory cytokine cascade in a patient. The compositions comprise, for example, high affinity antibodies that specifically bind HMG1 and antigenic fragments thereof. The high affinity antibodies of the present invention and pharmaceutical compositions comprising the same are useful for many purposes, for example, as therapeutics against a wide range of inflammatory diseases and disorders such as sepsis, rheumatoid arthritis, peritonitis, Crohn's disease, reperfusion injury, septicemia, endotoxic shock, cystic fibrosis, endocarditis, psoriasis, psoriatic arthritis, arthritis, anaphylactic shock, organ ischemia, reperfusion injury, and allograft rejection. In addition, the high affinity antibodies of the present inventions are useful as diagnostic antibodies.
摘要翻译: 公开了用于抑制促炎细胞因子从脊椎动物细胞中释放并抑制患者炎性细胞因子级联的组合物和方法。 组合物包含例如特异性结合HMG1的高亲和力抗体及其抗原性片段。 本发明的高亲和力抗体和包含其的药物组合物可用于许多目的,例如作为针对广泛范围的炎性疾病和病症的治疗剂,例如败血症,类风湿性关节炎,腹膜炎,克罗恩病,再灌注损伤,败血症 内毒素性休克,囊性纤维化,心内膜炎,牛皮癣,牛皮癣关节炎,关节炎,过敏性休克,器官缺血,再灌注损伤和同种异体移植排斥。 此外,本发明的高亲和力抗体可用作诊断抗体。
-
3.
公开(公告)号:US20090169546A1
公开(公告)日:2009-07-02
申请号:US12094447
申请日:2006-11-27
申请人: Herren Wu , Changshou Gao , Ling-Ling An , Peter Kiener , Su-Yau Mao , Anthony Coyle , Jane Tian , Theresa O'Keefe , Shixin Qin
发明人: Herren Wu , Changshou Gao , Ling-Ling An , Peter Kiener , Su-Yau Mao , Anthony Coyle , Jane Tian , Theresa O'Keefe , Shixin Qin
IPC分类号: A61K39/395 , C07K16/00 , G01N33/53 , C12Q1/68 , A61P37/06
CPC分类号: C07K16/24 , A61K2039/505 , C07K2317/21 , C07K2317/55 , C07K2317/73 , C07K2317/76 , C07K2317/92 , C07K2319/32
摘要: Compositions and methods are disclosed for inhibiting the release of a proinflammatory cytokine from a vertebrate cell, and for inhibiting an inflammatory cytokine cascade in a patient. The compositions comprise, for example, high affinity antibodies that specifically bind HMG1 and antigenic fragments thereof. The high affinity antibodies of the present invention and pharmaceutical compositions comprising the same are useful for many purposes, for example, as therapeutics against a wide range of inflammatory diseases and disorders such as sepsis, rheumatoid arthritis, peritonitis, Crohn s disease, reperfusion injury, septicemia, endotoxic shock, cystic fibrosis, endocarditis, psoriasis, psoriatic arthritis, arthritis, anaphylactic shock, organ ischemia, reperfusion injury, and allograft rejection. In addition, the high affinity antibodies of the present inventions are useful as diagnostic antibodies.
摘要翻译: 公开了用于抑制促炎细胞因子从脊椎动物细胞中释放并抑制患者炎性细胞因子级联的组合物和方法。 组合物包含例如特异性结合HMG1的高亲和力抗体及其抗原性片段。 本发明的高亲和力抗体和包含其的药物组合物可用于许多目的,例如作为针对广泛范围的炎性疾病和病症的治疗剂,例如败血症,类风湿性关节炎,腹膜炎,克罗恩病,再灌注损伤, 败血症,内毒素性休克,囊性纤维化,心内膜炎,牛皮癣,牛皮癣关节炎,关节炎,过敏性休克,器官缺血,再灌注损伤和同种异体移植排斥。 此外,本发明的高亲和力抗体可用作诊断抗体。
-
4.
公开(公告)号:US07964706B2
公开(公告)日:2011-06-21
申请号:US12094447
申请日:2006-11-27
申请人: Herren Wu , Changshou Gao , Ling-Ling An , Peter Kiener , Su-Yau Mao , Anthony Coyle , Jane Tian
发明人: Herren Wu , Changshou Gao , Ling-Ling An , Peter Kiener , Su-Yau Mao , Anthony Coyle , Jane Tian
IPC分类号: C07K16/00
CPC分类号: C07K16/24 , A61K2039/505 , C07K2317/21 , C07K2317/55 , C07K2317/73 , C07K2317/76 , C07K2317/92 , C07K2319/32
摘要: Compositions and methods are disclosed for inhibiting the release of a proinflammatory cytokine from a vertebrate cell, and for inhibiting an inflammatory cytokine cascade in a patient. The compositions comprise, for example, high affinity antibodies that specifically bind HMG1 and antigenic fragments thereof. The high affinity antibodies of the present invention and pharmaceutical compositions comprising the same are useful for many purposes, for example, as therapeutics against a wide range of inflammatory diseases and disorders such as sepsis, rheumatoid arthritis, peritonitis, Crohn s disease, reperfusion injury, septicemia, endotoxic shock, cystic fibrosis, endocarditis, psoriasis, psoriatic arthritis, arthritis, anaphylactic shock, organ ischemia, reperfusion injury, and allograft rejection. In addition, the high affinity antibodies of the present inventions are useful as diagnostic antibodies.
摘要翻译: 公开了用于抑制促炎细胞因子从脊椎动物细胞中释放并抑制患者炎性细胞因子级联的组合物和方法。 组合物包含例如特异性结合HMG1的高亲和力抗体及其抗原性片段。 本发明的高亲和力抗体和包含其的药物组合物可用于许多目的,例如作为针对广泛范围的炎性疾病和病症的治疗剂,例如败血症,类风湿性关节炎,腹膜炎,克罗恩病,再灌注损伤, 败血症,内毒素性休克,囊性纤维化,心内膜炎,牛皮癣,牛皮癣关节炎,关节炎,过敏性休克,器官缺血,再灌注损伤和同种异体移植排斥。 此外,本发明的高亲和力抗体可用作诊断抗体。
-
5.
公开(公告)号:US07585504B2
公开(公告)日:2009-09-08
申请号:US11254679
申请日:2005-10-21
申请人: Herren Wu , Christian B. Allan , Changshou Gao , Ling-Ling An , Peter Kiener , Su-Yau Mao , Anthony Coyle
发明人: Herren Wu , Christian B. Allan , Changshou Gao , Ling-Ling An , Peter Kiener , Su-Yau Mao , Anthony Coyle
IPC分类号: A61K39/395
CPC分类号: C07K16/24 , A61K2039/505 , C07K2317/21 , C07K2317/55 , C07K2317/565 , C07K2317/76 , C07K2317/92 , C07K2319/30 , Y02A50/412
摘要: Compositions and methods are disclosed for inhibiting the release of a proinflammatory cytokine from a vertebrate cell, and for inhibiting an inflammatory cytokine cascade in a patient. The compositions comprise, for example, high affinity antibodies that specifically bind HMG1 and antigenic fragments thereof. The high affinity antibodies of the present invention and pharmaceutical compositions comprising the same are useful for many purposes, for example, as therapeutics against a wide range of inflammatory diseases and disorders such as sepsis, rheumatoid arthritis, peritonitis, Crohn's disease, reperfusion injury, septicemia, endotoxic shock, cystic fibrosis, endocarditis, psoriasis, psoriatic arthritis, arthritis, anaphylactic shock, organ ischemia, reperfusion injury, and allograft rejection. In addition, the high affinity antibodies of the present inventions are useful as diagnostic antibodies.
摘要翻译: 公开了用于抑制促炎细胞因子从脊椎动物细胞中释放并抑制患者炎性细胞因子级联的组合物和方法。 组合物包含例如特异性结合HMG1的高亲和力抗体及其抗原性片段。 本发明的高亲和力抗体和包含其的药物组合物可用于许多目的,例如作为针对广泛范围的炎性疾病和病症的治疗剂,例如败血症,类风湿性关节炎,腹膜炎,克罗恩病,再灌注损伤,败血症 内毒素性休克,囊性纤维化,心内膜炎,牛皮癣,牛皮癣关节炎,关节炎,过敏性休克,器官缺血,再灌注损伤和同种异体移植排斥。 此外,本发明的高亲和力抗体可用作诊断抗体。
-
6.
公开(公告)号:US08153131B2
公开(公告)日:2012-04-10
申请号:US12534217
申请日:2009-08-03
申请人: Herren Wu , Christian Allan , Changshou Gao , Ling-Ling An , Peter Kiener , Su-Yau Mao , Anthony Coyle
发明人: Herren Wu , Christian Allan , Changshou Gao , Ling-Ling An , Peter Kiener , Su-Yau Mao , Anthony Coyle
IPC分类号: A61K39/395
CPC分类号: C07K16/24 , A61K2039/505 , C07K2317/21 , C07K2317/55 , C07K2317/565 , C07K2317/76 , C07K2317/92 , C07K2319/30 , Y02A50/412
摘要: Compositions and methods are disclosed for inhibiting the release of a proinflammatory cytokine from a vertebrate cell, and for inhibiting an inflammatory cytokine cascade in a patient. The compositions comprise, for example, high affinity antibodies that specifically bind HMG1 and antigenic fragments thereof. The high affinity antibodies of the present invention and pharmaceutical compositions comprising the same are useful for many purposes, for example, as therapeutics against a wide range of inflammatory diseases and disorders such as sepsis, rheumatoid arthritis, peritonitis, Crohn's disease, reperfusion injury, septicemia, endotoxic shock, cystic fibrosis, endocarditis, psoriasis, psoriatic arthritis, arthritis, anaphylactic shock, organ ischemia, reperfusion injury, and allograft rejection. In addition, the high affinity antibodies of the present inventions are useful as diagnostic antibodies.
摘要翻译: 公开了用于抑制促炎细胞因子从脊椎动物细胞中释放并抑制患者炎性细胞因子级联的组合物和方法。 组合物包含例如特异性结合HMG1的高亲和力抗体及其抗原性片段。 本发明的高亲和力抗体和包含其的药物组合物可用于许多目的,例如作为针对广泛范围的炎性疾病和病症的治疗剂,例如败血症,类风湿性关节炎,腹膜炎,克罗恩病,再灌注损伤,败血症 内毒素性休克,囊性纤维化,心内膜炎,牛皮癣,牛皮癣关节炎,关节炎,过敏性休克,器官缺血,再灌注损伤和同种异体移植排斥。 此外,本发明的高亲和力抗体可用作诊断抗体。
-
公开(公告)号:US20060099207A1
公开(公告)日:2006-05-11
申请号:US11254679
申请日:2005-10-21
申请人: Herren Wu , Christian Allan , Changshou Gao , Ling-Ling An , Peter Kiener , Su-Yau Mao , Anthony Coyle
发明人: Herren Wu , Christian Allan , Changshou Gao , Ling-Ling An , Peter Kiener , Su-Yau Mao , Anthony Coyle
IPC分类号: A61K39/395 , C07K16/40
CPC分类号: C07K16/24 , A61K2039/505 , C07K2317/21 , C07K2317/55 , C07K2317/565 , C07K2317/76 , C07K2317/92 , C07K2319/30 , Y02A50/412
摘要: Compositions and methods are disclosed for inhibiting the release of a proinflammatory cytokine from a vertebrate cell, and for inhibiting an inflammatory cytokine cascade in a patient. The compositions comprise, for example, high affinity antibodies that specifically bind HMG1 and antigenic fragments thereof. The high affinity antibodies of the present invention and pharmaceutical compositions comprising the same are useful for many purposes, for example, as therapeutics against a wide range of inflammatory diseases and disorders such as sepsis, rheumatoid arthritis, peritonitis, Crohn's disease, reperfusion injury, septicemia, endotoxic shock, cystic fibrosis, endocarditis, psoriasis, psoriatic arthritis, arthritis, anaphylactic shock, organ ischemia, reperfusion injury, and allograft rejection. In addition, the high affinity antibodies of the present inventions are useful as diagnostic antibodies.
-
8.
公开(公告)号:US20100061987A1
公开(公告)日:2010-03-11
申请号:US12534217
申请日:2009-08-03
申请人: Herren Wu , Christian B. Allan , Changshou Gao , Ling-Ling An , Peter Kiener , Su-Yau Mao , Anthony Coyle
发明人: Herren Wu , Christian B. Allan , Changshou Gao , Ling-Ling An , Peter Kiener , Su-Yau Mao , Anthony Coyle
IPC分类号: A61K39/395 , C07K16/18 , G01N33/53
CPC分类号: C07K16/24 , A61K2039/505 , C07K2317/21 , C07K2317/55 , C07K2317/565 , C07K2317/76 , C07K2317/92 , C07K2319/30 , Y02A50/412
摘要: Compositions and methods are disclosed for inhibiting the release of a proinflammatory cytokine from a vertebrate cell, and for inhibiting an inflammatory cytokine cascade in a patient. The compositions comprise, for example, high affinity antibodies that specifically bind HMG1 and antigenic fragments thereof. The high affinity antibodies of the present invention and pharmaceutical compositions comprising the same are useful for many purposes, for example, as therapeutics against a wide range of inflammatory diseases and disorders such as sepsis, rheumatoid arthritis, peritonitis, Crohn's disease, reperfusion injury, septicemia, endotoxic shock, cystic fibrosis, endocarditis, psoriasis, psoriatic arthritis, arthritis, anaphylactic shock, organ ischemia, reperfusion injury, and allograft rejection. In addition, the high affinity antibodies of the present inventions are useful as diagnostic antibodies.
摘要翻译: 公开了用于抑制促炎细胞因子从脊椎动物细胞中释放并抑制患者炎性细胞因子级联的组合物和方法。 组合物包含例如特异性结合HMG1的高亲和力抗体及其抗原性片段。 本发明的高亲和力抗体和包含其的药物组合物可用于许多目的,例如作为针对广泛范围的炎性疾病和病症的治疗剂,例如败血症,类风湿性关节炎,腹膜炎,克罗恩病,再灌注损伤,败血症 内毒素性休克,囊性纤维化,心内膜炎,牛皮癣,牛皮癣关节炎,关节炎,过敏性休克,器官缺血,再灌注损伤和同种异体移植排斥。 此外,本发明的高亲和力抗体可用作诊断抗体。
-
9.
公开(公告)号:US20080311122A1
公开(公告)日:2008-12-18
申请号:US12094449
申请日:2006-11-27
申请人: Herren Wu , Ling-Ling An , Peter Kiener , Anthony Coyle , Jane Tian , Changsou Gao
发明人: Herren Wu , Ling-Ling An , Peter Kiener , Anthony Coyle , Jane Tian , Changsou Gao
IPC分类号: A61K39/395 , A61K31/7105 , A61P37/02
CPC分类号: C07K16/24 , A61K2039/505 , C07K2317/21 , C07K2317/55 , C07K2317/73 , C07K2317/76 , C07K2317/92 , C07K2319/32
摘要: Compositions and methods are disclosed for inhibiting the release of a proinflammatory cytokine from a vertebrate cell, and for inhibiting an inflammatory cytokine cascade in a patient. The compositions comprise, for example, high affinity antibodies that specifically bind HMG1 and antigenic fragments thereof. The high affinity antibodies of the present invention and pharmaceutical compositions comprising the same are useful for many purposes, for example, as therapeutics against a wide range of inflammatory diseases and disorders such as sepsis, rheumatoid arthritis, peritonitis, Crohn s disease, reperfusion injury, septicemia, endotoxic shock, cystic fibrosis, endocarditis, lupus, psoriasis, psoriatic arthritis, arthritis, anaphylactic shock, organ ischemia, reperfusion injury, and allograft rejection. In addition, the high affinity antibodies of the present inventions are useful as diagnostic antibodies.
摘要翻译: 公开了用于抑制促炎细胞因子从脊椎动物细胞中释放并抑制患者炎性细胞因子级联的组合物和方法。 组合物包含例如特异性结合HMG1的高亲和力抗体及其抗原性片段。 本发明的高亲和力抗体和包含其的药物组合物可用于许多目的,例如作为针对广泛范围的炎性疾病和病症的治疗剂,例如败血症,类风湿性关节炎,腹膜炎,克罗恩病,再灌注损伤, 败血病,内毒素性休克,囊性纤维化,心内膜炎,狼疮,牛皮癣,牛皮癣关节炎,关节炎,过敏性休克,器官缺血,再灌注损伤和同种异体移植排斥。 此外,本发明的高亲和力抗体可用作诊断抗体。
-
公开(公告)号:US20110059100A1
公开(公告)日:2011-03-10
申请号:US12351145
申请日:2009-01-09
申请人: Jennifer L. Reed , Wendy I. White , Anthony Coyle , Alexander Kozhich , Jack Elias , Nanci Donacki , Changshou Gao , Herren Wu
发明人: Jennifer L. Reed , Wendy I. White , Anthony Coyle , Alexander Kozhich , Jack Elias , Nanci Donacki , Changshou Gao , Herren Wu
IPC分类号: A61K39/395 , C07K16/00 , A61P11/00
CPC分类号: C07K16/40 , A61K48/00 , A61K2039/505 , C07K2317/21 , C07K2317/52 , C07K2317/622 , C07K2317/76 , C07K2319/00 , C12N9/2442 , C12N15/86 , C12N2710/10343 , C12Y302/01014
摘要: The invention relates to the novel discovery that antagonizing a C/CLP can be useful for the treatment of diseases associated with the upregulation of one or more C/CLP such as Th2-driven and/or IL-13 mediated inflammatory diseases. Accordingly the present invention provides C/CLP antagonists and also provides compositions and methods for the prevention, management, treatment or amelioration of an inflammatory condition associated with the upregulation of a C/CLP or one or more symptoms thereof and/or the inhibition of IL-13 mediated inflammation.
摘要翻译: 本发明涉及拮抗C / CLP的新发现,可用于治疗与上调一种或多种C / CLP如Th2驱动和/或IL-13介导的炎性疾病相关的疾病。 因此,本发明提供了C / CLP拮抗剂,并且还提供了用于预防,治疗,改善与C / CLP或其一种或多种症状的上调相关的炎性病症和/或抑制IL的组合物和方法 -13介导的炎症。
-
-
-
-
-
-
-
-
-